Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 520-527

  Gangale, Maria F ^a   Miele, Luca ^a   Lanzone, Antonio ^b   Sagnella, Francesca ^a   Martinez, Daniela ^a   Tropea, Anna ^a   Moro, Francesca ^a   Morciano, Andrea ^a   Ciardulli, Andrea ^a   Palla, Carola ^a   Pompili, Maurizio ^a   Cefalo, Consuelo ^a   Grieco, Antonio ^a   Apa, Rosanna ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANDROGEN; ANDROSTENEDIONE; ASPARTATE AMINOTRANSFERASE; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; METFORMIN; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HOMEOSTASIS; HOMEOSTATIC MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER FUNCTION TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; THYROID FUNCTION TEST; TREATMENT DURATION; WAIST HIP RATIO;

ADULT; FEMALE; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; LIVER; METABOLIC SYNDROME X; METFORMIN; OVERWEIGHT; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 80052529243     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04093.x     Document Type: Article

References (31)

1. Azziz, R., Woods, K.S., Reyna, R., et al. (2004) The prevalence and feautures of the polycistyc ovary syndrome in an unselected population. Journal of Clinical Endocrinology and Metabolism, 89, 2745-2749. (Pubitemid 38766360)
2. Azziz, R., Carmina, E., Dewailly, D., et al. (2006) Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. Journal of Clinical Endocrinology and Metabolism, 91, 4237-4245. (Pubitemid 44833391)
3. Goodarzi, M.O., Dumesic, D.A., Chazenbalk, G., et al. (2011) Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nature Reviews. Endocrinology, 7, 219-231.
4. Legro, R.S., Finegood, D., &, Dunaif, A., (1998) A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 83, 2694-2698. (Pubitemid 28493762)
5. Chitturi, S., Abeygunasekera, S., Farrell, G.C., et al. (2002) Nash and insulin resistance: insulin hypersecretion and specific association with the insulin resistence syndrome. Hepatology, 35, 373-379. (Pubitemid 34106377)
6. Utzschneider, K.M., &, Kahn, S.E., (2006) Review: the role of insulin resistance in nonalcoholic fatty liver disease. Journal of Clinical Endocrinology and Metabolism, 91, 4753-4761. (Pubitemid 44917301)
7. Matteoni, C.A., Younossi, Z.M., Gramlich, T., et al. (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 116, 1413-1419. (Pubitemid 29258890)
8. Brzozowska, M.M., Ostapowicz, G., &, Weltman, M.D., (2009) An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. Gastroenterologia y Hepatologia, 24, 243-247.
9. Chang, R.J., (1983) Insulin resistance in non obese patients with polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism, 57, 356-361.
10. Hossain, N., Afendy, A., Stepanova, M., et al. (2009) Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 7, 1224-1229.
11. Cerda, C., Pérez- Ayuso, R.M., Riquelme, A., et al. (2007) Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Journal of Hepatology, 47, 412-417. (Pubitemid 47176161)
12. Setji, T.L., Holland, N.D., Sanders, L.L., et al. (2006) Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 91, 4237-4245.
13. Schwimmer, J.B., Khorram, O., Chiu, V., et al. (2005) Abnormal aminotransferase activity in women with polycystic ovary syndrome. Fertility and Sterility, 83, 494-497. (Pubitemid 40221817)
14. Prati, D., Taioli, E., Zanella, A., et al. (2002) Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine, 137, 1-10.
15. Angulo, P., Hui, J., Marchesini, G., et al. (2007) The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology, 45, 847-854.
16. Bonora, E., Targher, G., Alberiche, M., et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degree of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57-63. (Pubitemid 30022895)
17. Ciampelli, M., Leoni, F., Cucinelli, F., et al. (2005) Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. Journal of Clinical Endocrinology and Metabolism, 90, 1398-1406. (Pubitemid 40463995)
18. Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 16, 285, 2486-2497.
19. Li, Y.Y., Wang, X.M., Zhang, Y.X., et al. (2010) Ultrasonic elastography in clinica quantitative assessment of fatty liver. World Journal of Gastroenterology, 16, 4733-4737.
20. Bhattacharya, S.M., (2010) Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. Gynecological Endocrinology, 26, 516-520.
21. Essah, P.A., Wickham, E.P., &, Nestler, J.E., (2006) The metabolic syndrome in polycystic ovary syndrome. Journal of Endocrinological Investigation, 29, 270-280.
22. Paschos, P., &, Paletas, K., (2009) Nonalcoholic fatty liver disease and metabolic syndrome. Hippokratia, 13, 9-19.
23. Hsiao, P.J., Kuo, K.K., Shin, S.J., et al. (2007) Significant correlations between severe fatty liver and risk factors for metabolic syndrome. Journal of Gastroenterology and Hepatology, 22, 2118-2123.
24. Chen, M.J., Chiu, H.M., Chen, C.L., et al. (2010) Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 95, 3332-3341.
25. Setji, T.L., Holland, N.D., Sanders, L.L., et al. (2006) Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 91, 1741-1747.
26. Gambarin-Gelwan, M., Kinkhabwala, S.V., Schiano, T.D., et al. (2007) Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Clinical Gastroenterology and Hepatology, 5, 496-501. (Pubitemid 46575354)
27. Markou, A., Androulakis I.I., Mourmouris, C., et al. (2010) Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome. Fertility and Sterility, 93, 1220-1226.
28. Targher, G., Solagna, E., Tosi, F., et al. (2009) Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome. Journal of Endocrinological Investigation, 32, 695-700, Epub 2009 Jun 18.
29. Genazzani, A.D., Strucchi, C., Luisi, M., et al. (2006) Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecological Endocrinology, 22, 36-43. (Pubitemid 43355096)
30. Botwood, N., Hamilton-Fairley, D., Kiddy, D., et al. (1995) Sex hormone-binding globulin and female reproductive function. Journal of Steroid Biochemistry and Molecular Biology, 53, 529-531.
31. Cheang, K.I., Sharma, S.T., &, Nestler, J.E., (2006) Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome? Gynecological Endocrinology, 22, 595-604. (Pubitemid 44915725)